DK1554381T3 - Posttranskriptionel silencing af vævsfaktorekspression med korte interfererende RNA'er - Google Patents

Posttranskriptionel silencing af vævsfaktorekspression med korte interfererende RNA'er

Info

Publication number
DK1554381T3
DK1554381T3 DK03703543.3T DK03703543T DK1554381T3 DK 1554381 T3 DK1554381 T3 DK 1554381T3 DK 03703543 T DK03703543 T DK 03703543T DK 1554381 T3 DK1554381 T3 DK 1554381T3
Authority
DK
Denmark
Prior art keywords
tissue factor
short interfering
interfering rnas
factor expression
posttranscriptional silencing
Prior art date
Application number
DK03703543.3T
Other languages
Danish (da)
English (en)
Inventor
Eshrat Babaie
Hans Peter B Prydz
Torgeir Holen
Mohammed Amarzguioui
Merete Wiiger
Original Assignee
Sirnasense As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20020612A external-priority patent/NO20020612D0/no
Priority claimed from NO20024987A external-priority patent/NO20024987D0/no
Application filed by Sirnasense As filed Critical Sirnasense As
Application granted granted Critical
Publication of DK1554381T3 publication Critical patent/DK1554381T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK03703543.3T 2002-02-07 2003-02-06 Posttranskriptionel silencing af vævsfaktorekspression med korte interfererende RNA'er DK1554381T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NO20020612A NO20020612D0 (no) 2002-02-07 2002-02-07 Posttranskripsjonell inhibering ved korte interfererende RNA
US35451502P 2002-02-08 2002-02-08
NO20024987A NO20024987D0 (no) 2002-02-07 2002-10-16 Posttranskripsjonell inhibering ved korte interfererende RNA'er
PCT/NO2003/000045 WO2003066650A2 (en) 2002-02-07 2003-02-06 Short interfering rna molecules directed towards a tissue factor coding nucleic acid

Publications (1)

Publication Number Publication Date
DK1554381T3 true DK1554381T3 (da) 2010-03-29

Family

ID=27738950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03703543.3T DK1554381T3 (da) 2002-02-07 2003-02-06 Posttranskriptionel silencing af vævsfaktorekspression med korte interfererende RNA'er

Country Status (9)

Country Link
EP (1) EP1554381B1 (enExample)
JP (1) JP4335012B2 (enExample)
AT (1) ATE449846T1 (enExample)
AU (1) AU2003206267B2 (enExample)
CA (1) CA2475447A1 (enExample)
DE (1) DE60330263D1 (enExample)
DK (1) DK1554381T3 (enExample)
ES (1) ES2336440T3 (enExample)
WO (1) WO2003066650A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1660658A2 (en) * 2003-08-06 2006-05-31 Hans Peter B. Prydz The use of sirna silencing in the prevention of metastasis
US7919583B2 (en) 2005-08-08 2011-04-05 Discovery Genomics, Inc. Integration-site directed vector systems
WO2010008562A2 (en) 2008-07-16 2010-01-21 Recombinetics Methods and materials for producing transgenic animals
WO2011084193A1 (en) * 2010-01-07 2011-07-14 Quark Pharmaceuticals, Inc. Oligonucleotide compounds comprising non-nucleotide overhangs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387366B1 (en) * 1998-12-31 2002-05-14 Alg Company Methods for reducing adverse side effects associated with cellular transplantation
EP1429650B1 (en) * 2001-08-30 2009-06-24 Mount Sinai School of Medicine of New York University Alternatively spliced circulating tissue factor

Also Published As

Publication number Publication date
WO2003066650A2 (en) 2003-08-14
WO2003066650A3 (en) 2004-05-21
ES2336440T3 (es) 2010-04-13
CA2475447A1 (en) 2003-08-14
EP1554381B1 (en) 2009-11-25
JP2005532038A (ja) 2005-10-27
AU2003206267B2 (en) 2008-10-02
AU2003206267A1 (en) 2003-09-02
DE60330263D1 (de) 2010-01-07
ATE449846T1 (de) 2009-12-15
EP1554381A2 (en) 2005-07-20
JP4335012B2 (ja) 2009-09-30

Similar Documents

Publication Publication Date Title
DE602005015994D1 (de) siRNA-VERMITTELTES GEN-SILENCING VON ALPHA-SYNUKLEIN
AU2003261231A8 (en) Modified small interfering rna molecules and methods of use
ATE513843T1 (de) Abstellen von genen in vivo durch chemischmodifizierte und stabile sirna
DK2230304T3 (da) IRNA-modulering af RSV og terapeutiske anvendelser deraf
EA200870366A1 (ru) Короткая внутренне сегментированная интерферирующая рнк
WO2004028471A3 (en) Influenza therapeutic
WO2004058940A3 (en) Sirna-mediated gene silencing
WO2020198509A3 (en) Modified oligonucleotides with increased stability
EP4174179A3 (en) Rna containing modified nucleosides and methods of use thereof
NO20075655L (no) Terapeutisk RNAI for respiratorisk virusinfeksjon
DE602004029608D1 (de) Mutantes herpes-simplex-virus und verwendung davon bei der behandlung von plattenepithelkarzinom
WO2006083800A3 (en) Nucleic acid silencing of huntington's disease gene
ATE447024T1 (de) Stabilisierte rnas als transfektionskontrollen und silencing-reagentien
WO2006062596A3 (en) RNAi MODULATION OF RSV, PIV AND OTHER RESPIRATORY VIRUSES AND USES THEREOF
WO2006031901A3 (en) SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF
TW200508247A (en) Sars
BR112014010134A2 (pt) inibição da expressão genética viral
ATE518954T1 (de) Kleine interferierende rna-moleküle gegen ribonukleotidreduktase und ihre verwendungen
DK1554381T3 (da) Posttranskriptionel silencing af vævsfaktorekspression med korte interfererende RNA'er
WO2007032794A3 (en) Inhibition of viral gene expression using small interfering rna
EP2772541A3 (en) Targeting opposite strand replication intermediates of hepatitis C virus by RNAi
SG136969A1 (en) Influenza therapeutic
WO2005040187A3 (en) The use of sirna silencing in the prevention of metastasis
ATE536408T1 (de) Modifizierte polynukleotide zur verwendung bei rna-interferenz
WO2006092714A3 (en) Inhibition of spag9 expression with sirnas